Fluoxetine treatment of anorexia nervosa: an open clinical trial.
Six patients with chronic, refractory anorexia nervosa were treated with fluoxetine. Depressive symptoms diminished in all patients, and this was associated with weight gain. Subjects, despite frequent medical comorbidity, tolerated fluoxetine well, even in dosages greater than those used for depression.
Gwirtsman
H E
HE
Unit on Eating Disorders, National Institute of Mental Health, Bethesda, Md. 20892.
Guze
B H
BH
Yager
J
J
Gainsley
B
B
D000328:Adult; D000856:Anorexia Nervosa / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D001835:Body Weight; D000075202:Contraindications; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male
D005473:Fluoxetine